AI Search Is Rewriting the Patient Journey — And Most Pharma Teams Haven’t Noticed
For two decades, pharmaceutical commercial teams built their patient journey models around a predictable sequence: symptom onset, physician visit, diagnosis, […]
When AI Prescribes Trouble: The Legal Ambiguity Pharma Can’t Ignore
ChatGPT, Gemini, and Claude are answering drug questions millions of times a day. Some of those answers are wrong. Here
AI Gets Oncology Drugs Wrong: What Pharma Brand Teams Must Track Now
Ask ChatGPT whether pembrolizumab is approved for small cell lung cancer. The answer you get depends on which version you
AI Doesn’t Read Drug Labels Like Humans Do — And Pharma Is Paying the Price
When a patient types “can I take Ozempic with metformin” into ChatGPT, they are not reading an FDA-approved label. They
Pharma’s New Channel Problem: How AI Assistants Are Reshaping Drug Brand Visibility, Patient Safety, and Regulatory Risk
When a patient types “What’s the difference between Ozempic and Mounjaro?” into ChatGPT, no medical affairs team reviews the answer
Catch It Before It Escalates: How to Monitor AI Mentions of Your Drug for Early Safety Signals
In February 2023, a wave of posts began appearing on Reddit’s r/antidepressants forum describing a specific withdrawal effect from a
Generic Drug Makers Are Losing the AI Search War. Here’s the Fix.
When a patient types ‘What’s the best treatment for type 2 diabetes?’ into ChatGPT, the answer they get back is
Biosimilar AI Monitoring: The $100B Battle Playing Out in ChatGPT Right Now
Amgen’s Hadlima launched in the United States in July 2023. AbbVie’s Humira had dominated adalimumab prescribing for two decades. The
AI Drug Monitoring: The Pharma Playbook for LLM Brand Intelligence
Every day, millions of patients and physicians type drug questions into ChatGPT, Gemini, Perplexity, and Claude. They ask whether Ozempic
What AI Monitoring Reveals About Consumer Drug Confusion
When a patient types ‘Can I take Ozempic and metformin together?’ into ChatGPT, three things happen at once: ChatGPT generates
How Pharma Companies Monitor AI-Generated Drug Mentions Before the FDA Does
When a patient types ‘Is Ozempic safe for people with pancreatitis?’ into ChatGPT, the answer they receive is not written
When AI Mixes Clinical Data With Patient Stories: What Drug Companies Must Monitor Now
Ask ChatGPT about Ozempic’s side effects. You’ll get a confident paragraph that blends data from the SELECT cardiovascular outcomes trial
